Loss of Lung Mitochondrial Aconitase Activity Due to Hyperoxia in Bronchopulmonary Dysplasia in Primates
Overview
Authors
Affiliations
The premature primate exposed to hyperoxia provides a useful model of bronchopulmonary dysplasia. A critical target in hyperoxic injury is the mitochondrial matrix enzyme aconitase. We hypothesized that this enzyme's activity would decline in the premature baboon lung during exposure to hyperoxia. Total aconitase activity was significantly decreased in the lungs of premature baboons of 140 days gestation with exposure to 100% oxygen for 6-10 days compared with as needed [pro re nada (PRN)] oxygen exposure and fetal controls (P = 0.0001). In activity gels, lungs from 100% oxygen-exposed animals (6-10 days) showed a nearly complete loss of mitochondrial aconitase activity relative to lungs from animals exposed only to PRN oxygen. Decreased lung aconitase activity was not a nonspecific effect of hyperoxia, causing mitochondrial damage or loss, because the activity of the mitochondrial respiratory enzyme cytochrome oxidase was not different in lungs of 100% oxygen-exposed relative to PRN oxygen-exposed newborns. In 125-day-gestation premature primates (age 6-10 days), lung total aconitase activity was correlated with inspired oxygen tension (r = 0.73 for fraction of inspired oxygen > 0.35), whereas, for animals of 140 days gestation, no such correlation was found. Thus the more premature animal's lung was more susceptible to loss of aconitase.
Oxygen toxicity: cellular mechanisms in normobaric hyperoxia.
Alva R, Mirza M, Baiton A, Lazuran L, Samokysh L, Bobinski A Cell Biol Toxicol. 2022; 39(1):111-143.
PMID: 36112262 PMC: 9483325. DOI: 10.1007/s10565-022-09773-7.
Yue L, Lu X, Dennery P, Yao H Redox Biol. 2021; 48:102104.
PMID: 34417157 PMC: 8710987. DOI: 10.1016/j.redox.2021.102104.
Persistent increase in mitochondrial superoxide mediates cisplatin-induced chronic kidney disease.
Mapuskar K, Wen H, Holanda D, Rastogi P, Steinbach E, Han R Redox Biol. 2018; 20:98-106.
PMID: 30296702 PMC: 6174865. DOI: 10.1016/j.redox.2018.09.020.
Oxygen in mitochondrial disease: can there be too much of a good thing?.
Mootha V, Chinnery P J Inherit Metab Dis. 2018; 41(5):761-763.
PMID: 29948481 DOI: 10.1007/s10545-018-0210-3.
The Potentials and Caveats of Mesenchymal Stromal Cell-Based Therapies in the Preterm Infant.
Gronbach J, Shahzad T, Radajewski S, Chao C, Bellusci S, Morty R Stem Cells Int. 2018; 2018:9652897.
PMID: 29765429 PMC: 5911321. DOI: 10.1155/2018/9652897.